ANDLAUER HEALTHCARE GROUP IN (AND.CA) Fundamental Analysis & Valuation

TSX:AND • CA0342231077

Current stock price

54.97 CAD
+0.01 (+0.02%)
Last:

This AND.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. AND.CA Profitability Analysis

1.1 Basic Checks

  • AND had positive earnings in the past year.
  • AND had a positive operating cash flow in the past year.
  • Each year in the past 5 years AND has been profitable.
  • Each year in the past 5 years AND had a positive operating cash flow.
AND.CA Yearly Net Income VS EBIT VS OCF VS FCFAND.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

  • AND has a better Return On Assets (9.81%) than 80.00% of its industry peers.
  • Looking at the Return On Equity, with a value of 15.35%, AND belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
  • The Return On Invested Capital of AND (11.76%) is better than 86.67% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for AND is significantly above the industry average of 6.93%.
Industry RankSector Rank
ROA 9.81%
ROE 15.35%
ROIC 11.76%
ROA(3y)9.88%
ROA(5y)11.71%
ROE(3y)15.44%
ROE(5y)22.37%
ROIC(3y)11.97%
ROIC(5y)12.76%
AND.CA Yearly ROA, ROE, ROICAND.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • AND has a better Profit Margin (10.37%) than 86.67% of its industry peers.
  • AND's Profit Margin has been stable in the last couple of years.
  • AND has a Operating Margin of 13.99%. This is amongst the best in the industry. AND outperforms 86.67% of its industry peers.
  • In the last couple of years the Operating Margin of AND has remained more or less at the same level.
  • AND has a worse Gross Margin (33.85%) than 60.00% of its industry peers.
  • In the last couple of years the Gross Margin of AND has declined.
Industry RankSector Rank
OM 13.99%
PM (TTM) 10.37%
GM 33.85%
OM growth 3Y-4.81%
OM growth 5Y-1.42%
PM growth 3Y-21.44%
PM growth 5Y-0.72%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
AND.CA Yearly Profit, Operating, Gross MarginsAND.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. AND.CA Health Analysis

2.1 Basic Checks

  • AND has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for AND has been reduced compared to 1 year ago.
  • AND has more shares outstanding than it did 5 years ago.
  • AND has a worse debt/assets ratio than last year.
AND.CA Yearly Shares OutstandingAND.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AND.CA Yearly Total Debt VS Total AssetsAND.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 6.13 indicates that AND is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of AND (6.13) is better than 93.33% of its industry peers.
  • The Debt to FCF ratio of AND is 1.80, which is an excellent value as it means it would take AND, only 1.80 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 1.80, AND belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • AND has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
  • AND's Debt to Equity ratio of 0.21 is amongst the best of the industry. AND outperforms 93.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.8
Altman-Z 6.13
ROIC/WACC1.44
WACC8.16%
AND.CA Yearly LT Debt VS Equity VS FCFAND.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

  • AND has a Current Ratio of 1.35. This is a normal value and indicates that AND is financially healthy and should not expect problems in meeting its short term obligations.
  • AND has a better Current ratio (1.35) than 93.33% of its industry peers.
  • AND has a Quick Ratio of 1.30. This is a normal value and indicates that AND is financially healthy and should not expect problems in meeting its short term obligations.
  • AND has a Quick ratio of 1.30. This is amongst the best in the industry. AND outperforms 93.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.3
AND.CA Yearly Current Assets VS Current LiabilitesAND.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. AND.CA Growth Analysis

3.1 Past

  • AND shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.96%.
  • AND shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.82% yearly.
  • Looking at the last year, AND shows a small growth in Revenue. The Revenue has grown by 0.34% in the last year.
  • The Revenue has been growing by 17.53% on average over the past years. This is quite good.
EPS 1Y (TTM)1.96%
EPS 3Y-10.45%
EPS 5Y14.82%
EPS Q2Q%-10.53%
Revenue 1Y (TTM)0.34%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%-3%

3.2 Future

  • AND is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.62% yearly.
  • AND is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.95% yearly.
EPS Next Y6.54%
EPS Next 2Y10.13%
EPS Next 3Y8.62%
EPS Next 5YN/A
Revenue Next Year0.03%
Revenue Next 2Y1.88%
Revenue Next 3Y1.95%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AND.CA Yearly Revenue VS EstimatesAND.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
AND.CA Yearly EPS VS EstimatesAND.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

3

4. AND.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 35.24, the valuation of AND can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of AND indicates a somewhat cheap valuation: AND is cheaper than 66.67% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.87. AND is valued slightly more expensive when compared to this.
  • With a Price/Forward Earnings ratio of 28.68, AND can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, AND is valued a bit cheaper than the industry average as 73.33% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 38.51. AND is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 35.24
Fwd PE 28.68
AND.CA Price Earnings VS Forward Price EarningsAND.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AND indicates a somewhat cheap valuation: AND is cheaper than 66.67% of the companies listed in the same industry.
  • AND's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 21.69
EV/EBITDA 14.03
AND.CA Per share dataAND.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AND does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of AND may justify a higher PE ratio.
PEG (NY)5.39
PEG (5Y)2.38
EPS Next 2Y10.13%
EPS Next 3Y8.62%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. AND.CA Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.87%, AND is not a good candidate for dividend investing.
  • AND's Dividend Yield is a higher than the industry average which is at 1.36.
  • Compared to an average S&P500 Dividend Yield of 1.81, AND's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.87%

5.2 History

  • The dividend of AND decreases each year by -34.89%.
  • AND has been paying a dividend for over 5 years, so it has already some track record.
  • AND has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-34.89%
Div Incr Years3
Div Non Decr Years3
AND.CA Yearly Dividends per shareAND.CA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

  • AND pays out 26.73% of its income as dividend. This is a sustainable payout ratio.
DP26.73%
EPS Next 2Y10.13%
EPS Next 3Y8.62%
AND.CA Yearly Income VS Free CF VS DividendAND.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AND.CA Dividend Payout.AND.CA Dividend Payout, showing the Payout Ratio.AND.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

AND.CA Fundamentals: All Metrics, Ratios and Statistics

ANDLAUER HEALTHCARE GROUP IN

TSX:AND (11/4/2025, 7:00:00 PM)

54.97

+0.01 (+0.02%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-11
Earnings (Next)02-24
Inst Owners76.5%
Inst Owner ChangeN/A
Ins Owners2.53%
Ins Owner ChangeN/A
Market Cap2.15B
Revenue(TTM)650.58M
Net Income(TTM)67.49M
Analysts50
Price Target56.92 (3.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.87%
Yearly Dividend0.42
Dividend Growth(5Y)-34.89%
DP26.73%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.25%
Min EPS beat(2)-19.85%
Max EPS beat(2)-10.65%
EPS beat(4)0
Avg EPS beat(4)-9.2%
Min EPS beat(4)-19.85%
Max EPS beat(4)-0.99%
EPS beat(8)1
Avg EPS beat(8)-8.84%
EPS beat(12)3
Avg EPS beat(12)-6.41%
EPS beat(16)5
Avg EPS beat(16)11.49%
Revenue beat(2)0
Avg Revenue beat(2)-4.56%
Min Revenue beat(2)-7.25%
Max Revenue beat(2)-1.87%
Revenue beat(4)0
Avg Revenue beat(4)-3.59%
Min Revenue beat(4)-7.25%
Max Revenue beat(4)-1.87%
Revenue beat(8)1
Avg Revenue beat(8)-3.17%
Revenue beat(12)4
Avg Revenue beat(12)-1.94%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.43%
EPS NY rev (1m)-0.79%
EPS NY rev (3m)-6.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.5%
Valuation
Industry RankSector Rank
PE 35.24
Fwd PE 28.68
P/S 3.31
P/FCF 21.69
P/OCF 17.59
P/B 4.89
P/tB 17.04
EV/EBITDA 14.03
EPS(TTM)1.56
EY2.84%
EPS(NY)1.92
Fwd EY3.49%
FCF(TTM)2.53
FCFY4.61%
OCF(TTM)3.13
OCFY5.69%
SpS16.62
BVpS11.23
TBVpS3.23
PEG (NY)5.39
PEG (5Y)2.38
Graham Number19.8564 (-63.88%)
Profitability
Industry RankSector Rank
ROA 9.81%
ROE 15.35%
ROCE 16.09%
ROIC 11.76%
ROICexc 13.13%
ROICexgc 34.45%
OM 13.99%
PM (TTM) 10.37%
GM 33.85%
FCFM 15.25%
ROA(3y)9.88%
ROA(5y)11.71%
ROE(3y)15.44%
ROE(5y)22.37%
ROIC(3y)11.97%
ROIC(5y)12.76%
ROICexc(3y)12.48%
ROICexc(5y)13.78%
ROICexgc(3y)30.54%
ROICexgc(5y)29.2%
ROCE(3y)16.39%
ROCE(5y)17.47%
ROICexgc growth 3Y-1.36%
ROICexgc growth 5Y-1.14%
ROICexc growth 3Y4.48%
ROICexc growth 5Y-13.43%
OM growth 3Y-4.81%
OM growth 5Y-1.42%
PM growth 3Y-21.44%
PM growth 5Y-0.72%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
F-Score5
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.8
Debt/EBITDA 0.56
Cap/Depr 32.65%
Cap/Sales 3.56%
Interest Coverage 250
Cash Conversion 75.6%
Profit Quality 147.02%
Current Ratio 1.35
Quick Ratio 1.3
Altman-Z 6.13
F-Score5
WACC8.16%
ROIC/WACC1.44
Cap/Depr(3y)36.55%
Cap/Depr(5y)30.34%
Cap/Sales(3y)3.8%
Cap/Sales(5y)3.06%
Profit Quality(3y)141.22%
Profit Quality(5y)125.45%
High Growth Momentum
Growth
EPS 1Y (TTM)1.96%
EPS 3Y-10.45%
EPS 5Y14.82%
EPS Q2Q%-10.53%
EPS Next Y6.54%
EPS Next 2Y10.13%
EPS Next 3Y8.62%
EPS Next 5YN/A
Revenue 1Y (TTM)0.34%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%-3%
Revenue Next Year0.03%
Revenue Next 2Y1.88%
Revenue Next 3Y1.95%
Revenue Next 5YN/A
EBIT growth 1Y-1.92%
EBIT growth 3Y8.43%
EBIT growth 5Y15.86%
EBIT Next Year74.49%
EBIT Next 3Y25.3%
EBIT Next 5YN/A
FCF growth 1Y6.06%
FCF growth 3Y11.81%
FCF growth 5Y13.66%
OCF growth 1Y-1.91%
OCF growth 3Y13.94%
OCF growth 5Y15.32%

ANDLAUER HEALTHCARE GROUP IN / AND.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to AND.CA.


What is the valuation status of ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?

ChartMill assigns a valuation rating of 3 / 10 to ANDLAUER HEALTHCARE GROUP IN (AND.CA). This can be considered as Overvalued.


Can you provide the profitability details for ANDLAUER HEALTHCARE GROUP IN?

ANDLAUER HEALTHCARE GROUP IN (AND.CA) has a profitability rating of 7 / 10.


What are the PE and PB ratios of ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?

The Price/Earnings (PE) ratio for ANDLAUER HEALTHCARE GROUP IN (AND.CA) is 35.24 and the Price/Book (PB) ratio is 4.89.


What is the financial health of ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?

The financial health rating of ANDLAUER HEALTHCARE GROUP IN (AND.CA) is 8 / 10.